Gao Wei and Kuang Peizhu of Haiwen & Partners review the key developments in China’s capital markets in 2023, which included a seismic shift in regulation, and examine - with cautious optimism - the outlook for 2024
2023 was a highly significant year for the regulation of data protection in China. Casper Sek of Jingtian & Gongcheng charts the key developments
In 2023, the healthcare industry in China was subject to significant legislative advancements and reforms aimed at addressing industry concerns and promoting innovation. Hanshuo Zhou and Xiaoyun Wang of Jingtian & Gongcheng summarize the key events, and provide a reflective review based on their’ practical experience
In 2023, significant U.S. restrictions were placed on Chinese interests. Charles Wu of Clyde & Co reviews the legislative changes, and offers practical insights into their potential impact, and the path forward in 2024
Personal data transfer within the Greater Bay Area is made more convenient
Antitrust filing thresholds are raised
SPC clarifies application of international practice in foreign-related civil and commercial cases
Law firms may not simultaneously serve different parties in the same securities deal